Story perspectives

Trump Imposes 100% Tariff on Imported Pharmaceuticals Amid Controversy

4/9/2026

Summary

Story summary

U.S. President Donald Trump announced a 100% tariff on imported branded pharmaceuticals, effective in 120 to 180 days.
Sixteen major drugmakers, including Pfizer and Eli Lilly, are exempt due to pricing agreements.
Critics such as John Crowley, CEO of Biotechnology Innovation Organization, say tariffs raise costs and do not improve security.
The tariffs aim to reduce foreign reliance and bolster U.S. manufacturing amid China biotech competition, though impact remains unclear.

History

Historical Context

The Smoot-Hawley Tariff Act, signed by President Herbert Hoover on June 17, 1930, raised tariffs on over 20,000 goods to protect American industries during the Great Depression. This protectionist measure led to retaliatory tariffs from countries like Canada and the UK, causing a 66% drop in global trade. Today's proposed tariffs echo this historical trend, raising concerns about economic isolationism.

1 of 2

Story summary

U.S. President Donald Trump announced a 100% tariff on imported branded pharmaceuticals, effective in 120 to 180 days.
Sixteen major drugmakers, including Pfizer and Eli Lilly, are exempt due to pricing agreements.
Critics such as John Crowley, CEO of Biotechnology Innovation Organization, say tariffs raise costs and do not improve security.
The tariffs aim to reduce foreign reliance and bolster U.S. manufacturing amid China biotech competition, though impact remains unclear.

1 / 2